يعرض 1 - 10 نتائج من 155 نتيجة بحث عن '"Yael P. Mosse"', وقت الاستعلام: 1.59s تنقيح النتائج
  1. 1
    دورية أكاديمية
    Genomic Profiling of Childhood Tumor Patient-Derived Xenograft Models to Enable Rational Clinical Trial Design

    المؤلفون: Jo Lynne Rokita, Komal S. Rathi, Maria F. Cardenas, Kristen A. Upton, Joy Jayaseelan, Katherine L. Cross, Jacob Pfeil, Laura E. Egolf, Gregory P. Way, Alvin Farrel, Nathan M. Kendsersky, Khushbu Patel, Krutika S. Gaonkar, Apexa Modi, Esther R. Berko, Gonzalo Lopez, Zalman Vaksman, Chelsea Mayoh, Jonas Nance, Kristyn McCoy, Michelle Haber, Kathryn Evans, Hannah McCalmont, Katerina Bendak, Julia W. Böhm, Glenn M. Marshall, Vanessa Tyrrell, Karthik Kalletla, Frank K. Braun, Lin Qi, Yunchen Du, Huiyuan Zhang, Holly B. Lindsay, Sibo Zhao, Jack Shu, Patricia Baxter, Christopher Morton, Dias Kurmashev, Siyuan Zheng, Yidong Chen, Jay Bowen, Anthony C. Bryan, Kristen M. Leraas, Sara E. Coppens, HarshaVardhan Doddapaneni, Zeineen Momin, Wendong Zhang, Gregory I. Sacks, Lori S. Hart, Kateryna Krytska, Yael P. Mosse, Gregory J. Gatto, Yolanda Sanchez, Casey S. Greene, Sharon J. Diskin, Olena Morozova Vaske, David Haussler, Julie M. Gastier-Foster, E. Anders Kolb, Richard Gorlick, Xiao-Nan Li, C. Patrick Reynolds, Raushan T. Kurmasheva, Peter J. Houghton, Malcolm A. Smith, Richard B. Lock, Pichai Raman, David A. Wheeler, John M. Maris

    المصدر: Cell Reports, Vol 29, Iss 6, Pp 1675-1689.e9 (2019)

    مصطلحات موضوعية: Biology (General), QH301-705.5

    وصف الملف: electronic resource

    العلاقة: http://www.sciencedirect.com/science/article/pii/S2211124719312689Test; https://doaj.org/toc/2211-1247Test

    الوصول الحر: https://doaj.org/article/5a7054ef48fe4832b69df7b358c3a0d5Test

    View record in DOAJ النص الكامل

    أضف إلى المفضلة
  2. 2
    دورية أكاديمية
    Circulating tumor DNA reveals mechanisms of lorlatinib resistance in patients with relapsed/refractory ALK-driven neuroblastoma

    المؤلفون: Esther R. Berko, Gabriela M. Witek, Smita Matkar, Zaritza O. Petrova, Megan A. Wu, Courtney M. Smith, Alex Daniels, Joshua Kalna, Annie Kennedy, Ivan Gostuski, Colleen Casey, Kateryna Krytska, Mark Gerelus, Dean Pavlick, Susan Ghazarian, Julie R. Park, Araz Marachelian, John M. Maris, Kelly C. Goldsmith, Ravi Radhakrishnan, Mark A. Lemmon, Yaël P. Mossé

    المصدر: Nature Communications, Vol 14, Iss 1, Pp 1-13 (2023)

    مصطلحات موضوعية: Science

    العلاقة: https://doi.org/10.1038/s41467-023-38195-0Test; https://doaj.org/toc/2041-1723Test; https://doaj.org/article/c0e4bcb6136d4cc7a5072df22f3d7275Test

    الإتاحة: https://doi.org/10.1038/s41467-023-38195-0Test
    https://doaj.org/article/c0e4bcb6136d4cc7a5072df22f3d7275Test

    View record in BASE النص الكامل

    أضف إلى المفضلة
  3. 3
    Supplementary Figures S1-S4 from A Functional Screen Identifies miR-34a as a Candidate Neuroblastoma Tumor Suppressor Gene

    المؤلفون: John M. Maris, Garrett M. Brodeur, Sharon J. Diskin, Michael J. Laquaglia, Yael P. Mosse, Edward F. Attiyeh, Kristina A. Cole

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b262b2923f76e4b73f4bb4aad82ec86dTest
    https://doi.org/10.1158/1541-7786.22521316Test


    أضف إلى المفضلة
  4. 4
    Supplemental Table 1 from Phase II Trial of Alisertib in Combination with Irinotecan and Temozolomide for Patients with Relapsed or Refractory Neuroblastoma

    المؤلفون: Araz Marachelian, Katherine K. Matthay, Denice Tsao-Wei, Chunqiao Luo, Scarlett Czarnecki, Najee Boucher, Hiroyuki Shimada, Fariba Goodarzian, Hollie Lai, Jesse Courtier, Randall Hawkins, Lars M. Wagner, Greg Yanik, Susan L. Cohn, Margaret E. Macy, Julie R. Park, Brian Weiss, M. Meaghan Granger, Kelly Goldsmith, Clare J. Twist, John M. Maris, Rochelle Bagatell, Susan Groshen, Renee McGovern, Joel M. Reid, Rachel A. Kudgus, Elizabeth Fox, Yael P. Mosse, Steven G. DuBois

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8fd4fef903a7a83553b2ad1b6b1ee58bTest
    https://doi.org/10.1158/1078-0432.22469510.v1Test


    أضف إلى المفضلة
  5. 5
    Data from Phase II Trial of Alisertib in Combination with Irinotecan and Temozolomide for Patients with Relapsed or Refractory Neuroblastoma

    المؤلفون: Araz Marachelian, Katherine K. Matthay, Denice Tsao-Wei, Chunqiao Luo, Scarlett Czarnecki, Najee Boucher, Hiroyuki Shimada, Fariba Goodarzian, Hollie Lai, Jesse Courtier, Randall Hawkins, Lars M. Wagner, Greg Yanik, Susan L. Cohn, Margaret E. Macy, Julie R. Park, Brian Weiss, M. Meaghan Granger, Kelly Goldsmith, Clare J. Twist, John M. Maris, Rochelle Bagatell, Susan Groshen, Renee McGovern, Joel M. Reid, Rachel A. Kudgus, Elizabeth Fox, Yael P. Mosse, Steven G. DuBois

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2485f3121b3fe9d725c459bf2c01de63Test
    https://doi.org/10.1158/1078-0432.c.6527279.v1Test


    أضف إلى المفضلة
  6. 6
    Supplemental Figure 2 from Phase II Trial of Alisertib in Combination with Irinotecan and Temozolomide for Patients with Relapsed or Refractory Neuroblastoma

    المؤلفون: Araz Marachelian, Katherine K. Matthay, Denice Tsao-Wei, Chunqiao Luo, Scarlett Czarnecki, Najee Boucher, Hiroyuki Shimada, Fariba Goodarzian, Hollie Lai, Jesse Courtier, Randall Hawkins, Lars M. Wagner, Greg Yanik, Susan L. Cohn, Margaret E. Macy, Julie R. Park, Brian Weiss, M. Meaghan Granger, Kelly Goldsmith, Clare J. Twist, John M. Maris, Rochelle Bagatell, Susan Groshen, Renee McGovern, Joel M. Reid, Rachel A. Kudgus, Elizabeth Fox, Yael P. Mosse, Steven G. DuBois

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1880dad48c26376d3407c286813c4a7eTest
    https://doi.org/10.1158/1078-0432.22469516.v1Test


    أضف إلى المفضلة
  7. 7
    Supplemental Figure 1 from Phase II Trial of Alisertib in Combination with Irinotecan and Temozolomide for Patients with Relapsed or Refractory Neuroblastoma

    المؤلفون: Araz Marachelian, Katherine K. Matthay, Denice Tsao-Wei, Chunqiao Luo, Scarlett Czarnecki, Najee Boucher, Hiroyuki Shimada, Fariba Goodarzian, Hollie Lai, Jesse Courtier, Randall Hawkins, Lars M. Wagner, Greg Yanik, Susan L. Cohn, Margaret E. Macy, Julie R. Park, Brian Weiss, M. Meaghan Granger, Kelly Goldsmith, Clare J. Twist, John M. Maris, Rochelle Bagatell, Susan Groshen, Renee McGovern, Joel M. Reid, Rachel A. Kudgus, Elizabeth Fox, Yael P. Mosse, Steven G. DuBois

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5ffc34aee9c6ba8e7778deca2f2ed94cTest
    https://doi.org/10.1158/1078-0432.22469519.v1Test


    أضف إلى المفضلة
  8. 8
    Supplemental Figure Legends from Phase II Trial of Alisertib in Combination with Irinotecan and Temozolomide for Patients with Relapsed or Refractory Neuroblastoma

    المؤلفون: Araz Marachelian, Katherine K. Matthay, Denice Tsao-Wei, Chunqiao Luo, Scarlett Czarnecki, Najee Boucher, Hiroyuki Shimada, Fariba Goodarzian, Hollie Lai, Jesse Courtier, Randall Hawkins, Lars M. Wagner, Greg Yanik, Susan L. Cohn, Margaret E. Macy, Julie R. Park, Brian Weiss, M. Meaghan Granger, Kelly Goldsmith, Clare J. Twist, John M. Maris, Rochelle Bagatell, Susan Groshen, Renee McGovern, Joel M. Reid, Rachel A. Kudgus, Elizabeth Fox, Yael P. Mosse, Steven G. DuBois

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::39f9c0236f5d8ab34c60e9edd6137a2dTest
    https://doi.org/10.1158/1078-0432.22469513.v1Test


    أضف إلى المفضلة
  9. 9
    Supplemental Table 2 from Phase II Trial of Alisertib in Combination with Irinotecan and Temozolomide for Patients with Relapsed or Refractory Neuroblastoma

    المؤلفون: Araz Marachelian, Katherine K. Matthay, Denice Tsao-Wei, Chunqiao Luo, Scarlett Czarnecki, Najee Boucher, Hiroyuki Shimada, Fariba Goodarzian, Hollie Lai, Jesse Courtier, Randall Hawkins, Lars M. Wagner, Greg Yanik, Susan L. Cohn, Margaret E. Macy, Julie R. Park, Brian Weiss, M. Meaghan Granger, Kelly Goldsmith, Clare J. Twist, John M. Maris, Rochelle Bagatell, Susan Groshen, Renee McGovern, Joel M. Reid, Rachel A. Kudgus, Elizabeth Fox, Yael P. Mosse, Steven G. DuBois

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b5d9fd5b6fea9002b7bb80961f120331Test
    https://doi.org/10.1158/1078-0432.22469507.v1Test


    أضف إلى المفضلة
  10. 10
    Data from The B7-H3–Targeting Antibody–Drug Conjugate m276-SL-PBD Is Potently Effective Against Pediatric Cancer Preclinical Solid Tumor Models

    المؤلفون: John M. Maris, Peter J. Houghton, Raushan Kurmasheva, Richard Gorlick, Brad St. Croix, Yang Feng, Steven Seaman, Yifei Wang, Samson Ghilu, Matthew Tsang, David Groff, Khushbu Patel, Kateryna Krytska, Jennifer Pogoriler, Daniel Martinez, Yael P. Mosse, Eric J. Earley, Stephen W. Erickson, Beverly A. Teicher, Malcolm A. Smith, E. Anders Kolb, Jarrett Lindsay, Nathan M. Kendsersky

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ab5f7bd2b84ed5663da9919559459e8Test
    https://doi.org/10.1158/1078-0432.c.6530132.v1Test


    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث